These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 19246456)

  • 1. A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization.
    Yau MH; Wang Y; Lam KS; Zhang J; Wu D; Xu A
    J Biol Chem; 2009 May; 284(18):11942-52. PubMed ID: 19246456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL).
    Lee EC; Desai U; Gololobov G; Hong S; Feng X; Yu XC; Gay J; Wilganowski N; Gao C; Du LL; Chen J; Hu Y; Zhao S; Kirkpatrick L; Schneider M; Zambrowicz BP; Landes G; Powell DR; Sonnenburg WK
    J Biol Chem; 2009 May; 284(20):13735-13745. PubMed ID: 19318355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms.
    Shan L; Yu XC; Liu Z; Hu Y; Sturgis LT; Miranda ML; Liu Q
    J Biol Chem; 2009 Jan; 284(3):1419-24. PubMed ID: 19028676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4.
    Sonnenburg WK; Yu D; Lee EC; Xiong W; Gololobov G; Key B; Gay J; Wilganowski N; Hu Y; Zhao S; Schneider M; Ding ZM; Zambrowicz BP; Landes G; Powell DR; Desai U
    J Lipid Res; 2009 Dec; 50(12):2421-9. PubMed ID: 19542565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acids bind tightly to the N-terminal domain of angiopoietin-like protein 4 and modulate its interaction with lipoprotein lipase.
    Robal T; Larsson M; Martin M; Olivecrona G; Lookene A
    J Biol Chem; 2012 Aug; 287(35):29739-52. PubMed ID: 22773878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in ANGPTL4 provides insights into protein processing and function.
    Yin W; Romeo S; Chang S; Grishin NV; Hobbs HH; Cohen JC
    J Biol Chem; 2009 May; 284(19):13213-22. PubMed ID: 19270337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1.
    Chi X; Shetty SK; Shows HW; Hjelmaas AJ; Malcolm EK; Davies BS
    J Biol Chem; 2015 May; 290(19):11865-77. PubMed ID: 25809481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of triglyceride metabolism by Angiopoietin-like proteins.
    Mattijssen F; Kersten S
    Biochim Biophys Acta; 2012 May; 1821(5):782-9. PubMed ID: 22063269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases.
    Liu J; Afroza H; Rader DJ; Jin W
    J Biol Chem; 2010 Sep; 285(36):27561-70. PubMed ID: 20581395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietin-like protein 4 inhibition of lipoprotein lipase: evidence for reversible complex formation.
    Lafferty MJ; Bradford KC; Erie DA; Neher SB
    J Biol Chem; 2013 Oct; 288(40):28524-34. PubMed ID: 23960078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity.
    Kovrov O; Kristensen KK; Larsson E; Ploug M; Olivecrona G
    J Lipid Res; 2019 Apr; 60(4):783-793. PubMed ID: 30686789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of lipoprotein lipase in 3T3-L1 adipocytes by angiopoietin-like protein 4 requires that both proteins have reached the cell surface.
    Makoveichuk E; Vorrsjö E; Olivecrona T; Olivecrona G
    Biochem Biophys Res Commun; 2013 Nov; 441(4):941-6. PubMed ID: 24220340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity.
    Lei X; Shi F; Basu D; Huq A; Routhier S; Day R; Jin W
    J Biol Chem; 2011 May; 286(18):15747-56. PubMed ID: 21398697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance.
    Haller JF; Mintah IJ; Shihanian LM; Stevis P; Buckler D; Alexa-Braun CA; Kleiner S; Banfi S; Cohen JC; Hobbs HH; Yancopoulos GD; Murphy AJ; Gusarova V; Gromada J
    J Lipid Res; 2017 Jun; 58(6):1166-1173. PubMed ID: 28413163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of angiopoietin-like protein 3 and 4 reveals structural and mechanistic similarities.
    Gunn KH; Gutgsell AR; Xu Y; Johnson CV; Liu J; Neher SB
    J Biol Chem; 2021; 296():100312. PubMed ID: 33482195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4.
    Landfors F; Chorell E; Kersten S
    J Lipid Res; 2023 Jan; 64(1):100313. PubMed ID: 36372100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue.
    Sukonina V; Lookene A; Olivecrona T; Olivecrona G
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17450-5. PubMed ID: 17088546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism.
    Köster A; Chao YB; Mosior M; Ford A; Gonzalez-DeWhitt PA; Hale JE; Li D; Qiu Y; Fraser CC; Yang DD; Heuer JG; Jaskunas SR; Eacho P
    Endocrinology; 2005 Nov; 146(11):4943-50. PubMed ID: 16081640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopoietin-like protein 4(E40K) and ANGPTL4/8 complex have reduced, temperature-dependent LPL-inhibitory activity compared to ANGPTL4.
    Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Roell WC; Konrad RJ
    Biochem Biophys Res Commun; 2021 Jan; 534():498-503. PubMed ID: 33239171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the sites of the lipoprotein lipase (LPL)-angiopoietin-like protein 4 (ANGPTL4) interaction provides mechanistic insight into LPL inhibition.
    Gutgsell AR; Ghodge SV; Bowers AA; Neher SB
    J Biol Chem; 2019 Feb; 294(8):2678-2689. PubMed ID: 30591589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.